RGNX: REGENXBIO Company Short-Term Debts

RGNX (regenxbio.com) - company brandmark

REGENXBIO Inc. (RGNX) specializes in developing advanced treatments using genome and nucleic acid modification. Market dynamics for the securities on GURU.Markets show that the individual short-term debt metric is 0.04. The company relies on the development of NAV viral vectors and partnerships with major players to combat vision loss, aiming to bring innovative drugs to market.

RGNX (regenxbio.com) Short-Term Indebtedness history from 07/04/2022 to 10/31/2026

Financial and market metric breakdowns for REGENXBIO Corp (RGNX)

- current quotes and average value forecast:
Price Chart REGENXBIO|RGNX - Fair Value Consensus
- market capitalization information:
Market Capitalization REGENXBIO Inc.|RGNX - Total Enterprise Value
- business book valuation details:
Book Value per Share REGENXBIO|RGNX - Book Value of Business|Market Capitalization to Book Value Ratio regenxbio.com|RGNX - Company Assets
- debt and liquidity details:
Debt to Equity REGENXBIO Inc.|RGNX - Long-Term Debt to Capital Ratio|Short-Term Debt to Equity Ratio REGENXBIO Inc.|RGNX - Company Aggregate Debt|Debts to Book Capitalization REGENXBIO Inc.|RGNX - Company Long-Term Debt|Company Short-Term Debts REGENXBIO|Quick Liquidity regenxbio.com
- net income and valuation multiples indicators:
RGNX - Company Net Income
Fundamental valuation:REGENXBIO (RGNX)
Mass-produced product of regenxbio.com

REGENXBIO Inc. (RGNX) is developing a gene therapy ecosystem, leveraging patent protection for NAV Technology vectors to monetize licenses. An analysis of total short-term debt allows for an assessment of the company's current liquidity amid high capital expenditures. This metric measures the risk of cash flow gaps should operating revenues decline. A sharp increase in liabilities signals a funding shortage and creates potential for short positions. This indicator determines capital resilience to a sudden contraction in cash flow.

Competitor analysis for REGENXBIO Inc.

TEM - Company Short-Term Debt|Company Short-Term Loans and Borrowings QGEN (Qiagen NV)|IONS: Company Short-Term Debts|Short-Term Debt Repligen Inc. (RGEN)|RNA (Avidity Biosciences) - Company Short-Term Debts|CRSP - Short-Term Indebtedness|Company Short-Term Debts WGS|RARE - Short-Term Debt|Company Short-Term Debt Beam Therapeutics Corp BEAM|SRPT: Company Short-Term Indebtedness|TWST: Company Current Liabilities|TXG (10xgenomics.com) - Company Short-Term Indebtedness|NTLA: Company Short-Term Debts|STOK (Stoke Therapeutics Inc) - Company Short-Term Debt|BLFS (BioLife Corp) - Company Short-Term Debts|Wave Pharma (WVE) - Short-Term Debt Volume|Company Short-Term Debt Maze Therapeutics Inc (MAZE)|SION - Short-Term Debt|Prime Medicine - Company Current Liabilities|Company Short-Term Loans and Borrowings TSHA|uniQure Corp - Company Short-Term Debts|Short-Term Debt Volume MeiraGTx Corp MGTX|Solid Biosciences Inc. (SLDB) - Company Short-Term Debt|Company Short-Term Indebtedness OCGN|PACB (PacBio) - Company Short-Term Debts|Company Current Liabilities Benitec Biopharma Inc (BNTC)|Company Current Liabilities DSGN (Design Pharma)|Short-Term Debt Volume Rocket Corp|Company Short-Term Debt 4D Molecular Therapeutics FDMT|Company Short-Term Loans and Borrowings LXEO|Korro Bio, Inc - Company Short-Term Debts|Short-Term Indebtedness Editas Medicine Inc (EDIT)|Silence Therapeutics Inc. (SLN) - Company Short-Term Debt|Company Short-Term Indebtedness PRQR|Company Current Liabilities CDXS|Company Short-Term Indebtedness SGMO (sangamo.com)|Company Short-Term Debts NAUT|Metagenomi Inc. - Company Short-Term Indebtedness|Company Short-Term Debt Precision BioSciences DTIL|GBIO: Company Short-Term Indebtedness|Boundless Bio, Inc. - Company Short-Term Debts|XCUR - Company Short-Term Debts|imunon.com (IMNN) - Company Short-Term Debt|Phio Pharmaceuticals Corp. - Company Short-Term Loans and Borrowings|MBIO (Mustang Bio Inc) - Company Short-Term Debts|Short-Term Debt TransCode RNAZ|Company Short-Term Debts BNGO|adnas.com (APDN) - Short-Term Indebtedness|Company Short-Term Debts BLUE (bluebird bio)|ImmunoPrecise Antibodies Ltd (IPA) - Short-Term Debt|OMGA - Company Short-Term Debt|OMIC (Singular Genomics Corp) - Company Short-Term Indebtedness|RGLS (Regulus Therapeutics) - Company Current Liabilities|Company Short-Term Indebtedness SYRS|TBIO (Telesis Bio) - Company Short-Term Debts|Company Short-Term Debt TCON|Company Short-Term Debts UBX